Search

everythinglearnresearchcommunity

for

Search:↓

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Cooler scalp temperatures during chemotherapy may prevent hair loss.

Coenzyme Q10 may protect liver function but doesn't reduce hair loss from anthracycline antibiotics.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

Scalp cooling prevented hair loss in half of the patients, despite significant side effects.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

The treatment is safe and shows promise for metastatic breast cancer.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Scalp cooling is an effective and safe way to prevent hair loss from chemotherapy, with manageable side effects and low risk of scalp cancer.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Cooling can protect hair follicles from chemotherapy damage by reducing drug uptake.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

Scalp cooling effectively prevents hair loss in breast cancer patients undergoing chemotherapy.

Both scalp cooling and chemical cooling caps effectively prevent hair loss in breast cancer patients undergoing chemotherapy.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Scalp cooling effectively prevents chemotherapy-induced hair loss but requires better pain management.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.